STRAP
Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 2024. The company was founded in 2009 and is based in Herlev, Denmark.
Market Cap & Net Worth: STRAP (STRAP)
STRAP (CO:STRAP) has a market capitalization of $3.65 Million (Dkr26.55 Million) as of March 19, 2026. Listed on the CO stock exchange, this Denmark-based company holds position #35089 globally and #119 in its home market, demonstrating a 10.69% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying STRAP's stock price Dkr642.00 by its total outstanding shares 41349 (41.35K).
STRAP Market Cap History: 2025 to 2026
STRAP's market capitalization history from 2025 to 2026. Data shows growth from $3.97 Million to $3.65 Million (0.00% CAGR).
STRAP Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how STRAP's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of STRAP by Market Capitalization
Companies near STRAP in the global market cap rankings as of March 19, 2026.
Key companies related to STRAP by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
STRAP Historical Marketcap From 2025 to 2026
Between 2025 and today, STRAP's market cap moved from $3.97 Million to $ 3.65 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Dkr3.65 Million | -8.02% |
| 2025 | Dkr3.97 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of STRAP was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.65 Million USD |
| MoneyControl | $3.65 Million USD |
| MarketWatch | $3.65 Million USD |
| marketcap.company | $3.65 Million USD |
| Reuters | $3.65 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.